Cargando...

Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers

Technologies that facilitate the targeted manipulation of epigenetic marks could be used to precisely control cell phenotype or interrogate the relationship between the epigenome and transcriptional control. Here we have generated a programmable acetyltransferase based on the CRISPR/Cas9 gene regula...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Biotechnol
Main Authors: Hilton, Isaac B., D’Ippolito, Anthony M., Vockley, Christopher M., Thakore, Pratiksha I., Crawford, Gregory E., Reddy, Timothy E., Gersbach, Charles A.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4430400/
https://ncbi.nlm.nih.gov/pubmed/25849900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.3199
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!